Position in MRK
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$806,980
+$11,262 QoQ
Shares Held
6,280
-5.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#2,294
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRAPHAGEN INVESTMENT ADVISORS LLC holds $8,468,712 across 7 Drug Manufacturers - General names. MRK ranks #4 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,821 | $2,494,239 | |
| 2 | ABBV |
AbbVie Inc.
|
9,472 | $2,383,534 | |
| 3 | LLY |
ELI LILLY & Co
|
1,286 | $1,542,467 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
6,280 | $806,980 | |
| 5 | PFE |
Pfizer Inc
|
22,620 | $544,689 | |
| 6 | AMGN |
Amgen Inc
|
1,367 | $495,018 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,502 | $201,785 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $806,980 | 6,280 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $795,718 | 6,615 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $753,240 | 7,156 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $668,922 | 7,970 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $683,388 | 8,633 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $727,325 | 8,103 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $844,983 | 8,494 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,029,080 | 9,062 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,074,460 | 8,679 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,111,019 | 8,420 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $910,753 | 8,354 | Shares | Sole | 2024-06-17 | |
| 2023-09-30 | $785,611 | 7,631 | Shares | Sole | 2024-06-17 | |
| 2023-06-30 | $879,387 | 7,621 | Shares | Sole | 2024-06-17 | |
| 2023-03-31 | $799,627 | 7,516 | Shares | Sole | 2024-06-17 | |
| 2022-12-31 | $802,390 | 7,232 | Shares | Sole | 2024-06-17 | |
| 2022-09-30 | $638,149 | 7,410 | Shares | Sole | 2024-06-17 | |
| 2022-06-30 | $680,401 | 7,463 | Shares | Sole | 2024-06-17 | |
| 2022-03-31 | $603,149 | 7,351 | Shares | Sole | 2024-06-17 | |
| 2021-12-31 | $512,338 | 6,685 | Shares | Sole | 2024-06-17 | |
| 2021-09-30 | $492,195 | 6,553 | Shares | Sole | 2024-06-17 | |
| 2021-06-30 | $508,771 | 6,542 | Shares | Sole | 2024-06-17 | |
| 2021-03-31 | $510,875 | 6,627 | Shares | Sole | 2024-06-17 | |
| 2020-12-31 | $524,992 | 6,418 | Shares | Sole | 2024-06-17 | |
| 2020-09-30 | $535,774 | 6,459 | Shares | Sole | 2024-06-17 | |
| 2020-06-30 | $495,994 | 6,414 | Shares | Sole | 2024-06-17 | |
| 2020-03-31 | $458,946 | 5,965 | Shares | Sole | 2024-06-17 | |
| No filing history on record for this holder in this stock. | ||||||